Mayne Pharma Group Limited (MAYNF PINK) stock market data APIs
$4.0127
0(0%)
as of October 24, 2025
Try our APIs with
free plan!
Mayne Pharma Group Limited Financial Data Overview
Price chart is built with
Anychart
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Prev. Close
4.0127
Open
4.0127
High
4.0127
Low
4.0127
52 wk Range
2.415-4.6
Market Cap
327 M
Shares Outstanding
81 246 K
Revenue
408 M
EPS
-0.0064
Beta
1.205
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mayne Pharma Group Limited data using free add-ons & libraries
Get Mayne Pharma Group Limited Fundamental Data
Mayne Pharma Group Limited Fundamental data includes:
- Net Revenue: 408 M
- EBITDA: 42 078 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mayne Pharma Group Limited News
New
ASX Penny Stocks To Watch In September 2025
The Australian market is navigating a period of volatility following the Federal Reserve's decision to cut interest rates in the U.S., with local shares trending downward and futures for the ASX 200 s...
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ADELAIDE, Australia, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Mayne Pharma Group Limited (ASX: MYX) today announced that Shawn Patrick O’Brien, Chief Executive Officer of Mayne Pharma, will present at the ...
While institutions invested in Mayne Pharma Group Limited (ASX:MYX) benefited from last week's 12% gain, retail investors stood to gain the most
Key Insights Mayne Pharma Group's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 23 investors have a majority ...
Shawn O’Brien Buys Handful Of Shares In Mayne Pharma Group
Even if it's not a huge purchase, we think it was good to see that Shawn O’Brien, the CEO, MD & Director of Mayne Pharma Group Limited (ASX:MYX) recently shelled out AU$141k to buy stock, at AU$3.80...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
